» Articles » PMID: 29728434

Focal Segmental Glomerulosclerosis in a Patient with Prefibrotic Primary Myelofibrosis

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2018 May 6
PMID 29728434
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We report a case of 56-year-old man presented to us with chief complaints of frothy urine and leg swelling. A urinalysis revealed nephrotic-range proteinuria. Haematological investigations revealed thrombocytosis, leucocytosis and peripheral blood smear showed a leucoerythroblastic picture. JAK 2 mutation was positive. To confirm the diagnosis of myeloproliferative neoplasm, bone marrow biopsy was done, which was suggestive of primary myelofibrosis. The patient underwent kidney biopsy due to rapidly declining renal function and persistent proteinuria, which was suggestive of focal segmental glomerulosclerosis. Early glomerulopathy is rare in myeloproliferative neoplasm, and aggressive follow-up is required to prevent progression of kidney disease.

Citing Articles

Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases.

Popov H, Koleva T, Stoyanov G, Ghenev P Cureus. 2023; 14(12):e32388.

PMID: 36632253 PMC: 9830004. DOI: 10.7759/cureus.32388.


Immune Complex Associated Glomerulonephritis in a Patient with Prefibrotic Primary Myelofibrosis: A Case Report.

Atlani M, Sharma T, Joshi D, Kumar A Indian J Nephrol. 2021; 31(1):50-53.

PMID: 33994688 PMC: 8101669. DOI: 10.4103/ijn.IJN_222_19.


Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.

Belliere J, Colombat M, Kounde C, Recher C, Ribes D, Huart A Kidney Int Rep. 2021; 6(3):737-745.

PMID: 33732988 PMC: 7938079. DOI: 10.1016/j.ekir.2020.12.005.

References
1.
Kwak H, Lee J . CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys, in a patient with idiopathic myelofibrosis. J Korean Med Sci. 2000; 15(4):460-2. PMC: 3054659. DOI: 10.3346/jkms.2000.15.4.460. View

2.
Tefferi A . Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016; 91(12):1262-1271. DOI: 10.1002/ajh.24592. View

3.
Oesterling J, Keating J, LeRoy A, Earle J, Farrow G, McCARTHY J . Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. J Urol. 1992; 147(5):1360-2. DOI: 10.1016/s0022-5347(17)37566-3. View

4.
Mesa R, SILVERSTEIN M, Jacobsen S, Wollan P, Tefferi A . Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol. 1999; 61(1):10-5. DOI: 10.1002/(sici)1096-8652(199905)61:1<10::aid-ajh3>3.0.co;2-i. View

5.
Kaygusuz I, Koc M, Arikan H, Adiguzel C, Cakalagaoglu F, Tuglular T . Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis. Ren Fail. 2010; 32(2):273-6. DOI: 10.3109/08860220903573286. View